Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,785,400 | 716,000 | 351,000 | 1,399,400 | 1,029,700 |
| Depreciation Amortization | 112,600 | 78,100 | 38,500 | 144,900 | 108,200 |
| Income taxes - deferred | -224,900 | -101,900 | -35,800 | -272,100 | -180,700 |
| Accounts receivable | 15,300 | -32,000 | -55,000 | -141,200 | -123,000 |
| Other Working Capital | 203,800 | -479,800 | -453,800 | -526,300 | -310,200 |
| Other Operating Activity | -3,222,400 | 137,600 | 101,600 | 291,100 | 235,200 |
| Operating Cash Flow | $669,800 | $318,000 | $-53,500 | $895,800 | $759,200 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -202,600 | -150,700 | -65,300 | -253,000 | -164,700 |
| Net Acquisitions | -779,800 | -10,800 | -10,800 | -125,200 | -156,200 |
| Purchase Of Investment | -588,000 | -21,900 | -2,600 | -91,300 | -31,900 |
| Sale Of Investment | 589,500 | 413,600 | 166,600 | 715,800 | 578,400 |
| Purchase Sale Intangibles | -25,400 | -20,000 | -20,000 | -13,300 | -13,300 |
| Other Investing Activity | 3,870,500 | -42,300 | -24,800 | -72,500 | -65,900 |
| Investing Cash Flow | $2,889,600 | $187,900 | $63,100 | $173,800 | $159,700 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 150,900 | 116,400 | 62,100 | 169,900 | 136,700 |
| Common Stock Repurchased | -1,059,300 | -158,300 | -200 | -879,600 | -431,200 |
| Other Financing Activity | -103,200 | 7,000 | -200 | -1,300 | -3,300 |
| Financing Cash Flow | $-1,011,600 | $-34,900 | $61,700 | $-711,000 | $-297,800 |
| Exchange Rate Effect | -12,400 | 39,100 | 9,700 | 16,800 | 20,200 |
| Beginning Cash Position | 1,148,000 | 1,148,000 | 1,148,000 | 772,600 | 772,600 |
| End Cash Position | 3,683,400 | 1,658,100 | 1,229,000 | 1,148,000 | 1,413,900 |
| Net Cash Flow | $2,535,400 | $510,100 | $81,000 | $375,400 | $641,300 |
| Free Cash Flow | |||||
| Operating Cash Flow | 669,800 | 318,000 | -53,500 | 895,800 | 759,200 |
| Capital Expenditure | -202,600 | -150,700 | -65,300 | -253,000 | -164,700 |
| Free Cash Flow | 467,200 | 167,300 | -118,800 | 642,800 | 594,500 |